Insulinoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{ADS}} | {{CMG}}; {{AE}} {{ADS}} | ||
{{Insulinoma}} | {{Insulinoma}} | ||
| Line 9: | Line 10: | ||
*The incidence of insulinoma is approximately 0.1-0.4 per 100,000 individuals that constitute 1-2% of all pancreatic neoplasms.<ref name="pmid23430217">{{cite journal |vauthors=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K |title=Diagnosis and management of insulinoma |journal=World J. Gastroenterol. |volume=19 |issue=6 |pages=829–37 |year=2013 |pmid=23430217 |pmc=3574879 |doi=10.3748/wjg.v19.i6.829 |url=}}</ref><ref name="pmid1677058">{{cite journal |vauthors=Service FJ, McMahon MM, O'Brien PC, Ballard DJ |title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study |journal=Mayo Clin. Proc. |volume=66 |issue=7 |pages=711–9 |year=1991 |pmid=1677058 |doi= |url=}}</ref> | *The incidence of insulinoma is approximately 0.1-0.4 per 100,000 individuals that constitute 1-2% of all pancreatic neoplasms.<ref name="pmid23430217">{{cite journal |vauthors=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K |title=Diagnosis and management of insulinoma |journal=World J. Gastroenterol. |volume=19 |issue=6 |pages=829–37 |year=2013 |pmid=23430217 |pmc=3574879 |doi=10.3748/wjg.v19.i6.829 |url=}}</ref><ref name="pmid1677058">{{cite journal |vauthors=Service FJ, McMahon MM, O'Brien PC, Ballard DJ |title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study |journal=Mayo Clin. Proc. |volume=66 |issue=7 |pages=711–9 |year=1991 |pmid=1677058 |doi= |url=}}</ref> | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop | *Patients of all age groups may develop insulinoma | ||
* | *Insulinoma commonly affects individuals 40-60 years of age. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to insulinoma. | ||
===Gender=== | ===Gender=== | ||
* Females are more commonly (60-75%)<ref name="pmid1677058">{{cite journal |vauthors=Service FJ, McMahon MM, O'Brien PC, Ballard DJ |title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study |journal=Mayo Clin. Proc. |volume=66 |issue=7 |pages=711–9 |year=1991 |pmid=1677058 |doi= |url=}}</ref> affected by insulinoma than males. The female to male ratio is approximately 3:2. | * Females are more commonly (60-75%)<ref name="pmid1677058">{{cite journal |vauthors=Service FJ, McMahon MM, O'Brien PC, Ballard DJ |title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study |journal=Mayo Clin. Proc. |volume=66 |issue=7 |pages=711–9 |year=1991 |pmid=1677058 |doi= |url=}}</ref> affected by insulinoma than males. The female to male ratio is approximately 3:2. | ||
===Region=== | ===Region=== | ||
* | *There is no regional predisposition but it was described according to local studies. One of the best studies ever conducted for insulinoma, by Mayo clinic, showed the incidnece of insulinoma in residents of Olmsted county, Minnesota over the time frame of 60 years. | ||
==References== | ==References== | ||
Revision as of 03:08, 11 September 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Insulinoma epidemiology and demographics |
|
Risk calculators and risk factors for Insulinoma epidemiology and demographics |
Overview
Epidemiology and Demographics
Incidence
- The incidence of insulinoma is approximately 0.1-0.4 per 100,000 individuals that constitute 1-2% of all pancreatic neoplasms.[1][2]
Age
- Patients of all age groups may develop insulinoma
- Insulinoma commonly affects individuals 40-60 years of age.
Race
- There is no racial predilection to insulinoma.
Gender
- Females are more commonly (60-75%)[2] affected by insulinoma than males. The female to male ratio is approximately 3:2.
Region
- There is no regional predisposition but it was described according to local studies. One of the best studies ever conducted for insulinoma, by Mayo clinic, showed the incidnece of insulinoma in residents of Olmsted county, Minnesota over the time frame of 60 years.
References
- ↑ Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K (2013). "Diagnosis and management of insulinoma". World J. Gastroenterol. 19 (6): 829–37. doi:10.3748/wjg.v19.i6.829. PMC 3574879. PMID 23430217.
- ↑ 2.0 2.1 Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991). "Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study". Mayo Clin. Proc. 66 (7): 711–9. PMID 1677058.